{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:07:12Z","timestamp":1787022432368,"version":"build-2736575974"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Data are limited regarding the safety of 12-dose once-weekly isoniazid (H, 900 mg) plus rifapentine (P, 900 mg) (3HP) for latent infection treatment during pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To assess safety and pregnancy outcomes among pregnant women who were inadvertently exposed to study medications in two latent tuberculosis infection trials (PREVENT TB or iAdhere) evaluating 3HP and 9 months of daily isoniazid (H, 300 mg) (9H).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from reproductive-age (15\u201351 yr) women who received one or more study dose of 3HP or 9H in either trial were analyzed. Drug exposure during pregnancy occurred if the estimated date of conception was on or before the last dose date.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 126 pregnancies (125 participants) that occurred during treatment or follow-up, 87 were exposed to study drugs. Among these, fetal loss was reported for 4\/31 (13%) and 8\/56 (14%), 3HP and 9H, respectively (difference, 13%\u2009\u2212\u200914%\u2009=\u2009\u22121%; 95% confidence interval\u2009= \u221217% to +18%) and congenital anomalies in 0\/20 and 2\/41 (5%) live births, 3HP and 9H, respectively (difference, 0%\u2009\u2212\u20095%\u2009=\u2009\u22125%; 95% confidence interval\u2009=\u2009\u221218% to +16%). All fetal losses occurred in pregnancies of less than 20 weeks. Of the total 126 pregnancies, fetal loss was reported in 8\/54 (15%) and 9\/72 (13%), 3HP and 9H, respectively; and congenital anomalies in 1\/37 (3%) and 2\/56 (4%) live births, 3HP and 9H, respectively. The overall proportion of fetal loss (17\/126 [13%]) and anomalies (3\/93 [3%]) were similar to those estimated for the United States, 17% and 3%, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among reported pregnancies in these two latent tuberculosis infection trials, there was no unexpected fetal loss or congenital anomalies. These data offer some preliminary reassurance to clinicians and patients in circumstances when these drugs and regimens are the best option in pregnancy or in women of child-bearing potential.<\/jats:p>\n                    <jats:p>This work used the identifying trial registration numbers NCT00023452 and NCT01582711, corresponding to the primary clinical trials PREVENT TB and iAdhere (Tuberculosis Trials Consortium Study 26 and 33).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.201704-326oc","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T10:15:37Z","timestamp":1517566537000},"page":"570-580","source":"Crossref","is-referenced-by-count":56,"title":["Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials"],"prefix":"10.1093","volume":"15","author":[{"given":"Ruth N.","family":"Moro","sequence":"first","affiliation":[{"name":"Centers for Disease Control and Prevention (CDC), Atlanta, Georgia"},{"name":"CDC Foundation Research Collaboration, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel A.","family":"Scott","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention (CDC), Atlanta, Georgia"},{"name":"CDC Foundation Research Collaboration, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Vernon","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention (CDC), Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi K.","family":"Tepper","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention (CDC), Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan V.","family":"Goldberg","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention (CDC), Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Schwartzman","sequence":"additional","affiliation":[{"name":"McGill University Health Centre, Respiratory Epidemiology and Clinical Research Unit, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chiu","family":"Leung","sequence":"additional","affiliation":[{"name":"Tuberculosis and Chest Service, Department of Health, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil W.","family":"Schluger","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy and Critical Care Medicine, Columbia University Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Belknap","sequence":"additional","affiliation":[{"name":"Denver Health and Hospitals, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Chaisson","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine, Center for Tuberculosis Research, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Narita","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, Washington"},{"name":"Tuberculosis Control Program Public Health, King County, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth S.","family":"Machado","sequence":"additional","affiliation":[{"name":"Universidad Federal do Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Lopez","sequence":"additional","affiliation":[{"name":"Maternal\u2013Fetal Medicine Department, Hospital Clinic and Hospital Sant Joan de D\u00e9u, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Sanchez","sequence":"additional","affiliation":[{"name":"Asociaci\u00f3n Civil IMPACTA Salud y Educaci\u00f3n, Lima, Peru"},{"name":"Department of Global Health, University of Washington, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita E.","family":"Villarino","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention (CDC), Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Sterling","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,1]]},"reference":[{"key":"2026020502172327400_bib1","volume-title":". Controlling tuberculosis in the United States: recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America.","author":"Centers for Disease Control and Prevention","year":"2005"},{"key":"2026020502172327400_bib2","volume-title":"Global tuberculosis report 2015.","author":"World Health Organization","year":"2015"},{"key":"2026020502172327400_bib3","first-page":"194","article-title":"Tuberculosis and gender: exploring the patterns in a case control study in Malawi","volume":"8","author":"Crampin","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026020502172327400_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tube.2012.10.012","article-title":"The role of sex differences in the prevalence and transmission of tuberculosis","volume":"93","author":"Rhines","year":"2013","journal-title":"Tuberculosis (Edinb)"},{"key":"2026020502172327400_bib5","first-page":"96","article-title":"A review of sex differences in the epidemiology of tuberculosis","volume":"2","author":"Holmes","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026020502172327400_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0962-8479(96)90110-0","article-title":"Gender differentials in tuberculosis: the role of socio-economic and cultural factors","volume":"77","author":"Hudelson","year":"1996","journal-title":"Tuber Lung Dis"},{"key":"2026020502172327400_bib7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0171-2985(11)80437-7","article-title":"Tuberculosis: distribution, risk factors, mortality","volume":"191","author":"Kochi","year":"1994","journal-title":"Immunobiology"},{"key":"2026020502172327400_bib8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1086\/518974","article-title":"Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002\u20132005","volume":"45","author":"Gupta","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2026020502172327400_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140881","article-title":"Tuberculosis infection in the United States: prevalence estimates from the National Health and Nutrition Examination Survey, 2011\u20132012","volume":"10","author":"Miramontes","year":"2015","journal-title":"PLoS One"},{"key":"2026020502172327400_bib10","volume-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection.","author":"Centers for Disease Control & Prevention","year":"2000"},{"key":"2026020502172327400_bib11","volume-title":"Latent tuberculosis infection: a guide for primary health care providers.","author":"Centers for Disease Control & Prevention","year":"2013"},{"key":"2026020502172327400_bib12","first-page":"151","article-title":"Isoniazid hepatitis among pregnant and postpartum Hispanic patients","volume":"104","author":"Franks","year":"1989","journal-title":"Public Health Rep"},{"key":"2026020502172327400_bib13","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"2026020502172327400_bib14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/M17-1150","article-title":"Self-administered versus directly observed once-weekly isoniazid and rifapentine treatment of latent tuberculosis infection: a randomized trial","volume":"167","author":"Belknap","year":"2017","journal-title":"Ann Intern Med"},{"key":"2026020502172327400_bib15"},{"key":"2026020502172327400_bib16","first-page":"A7859","article-title":"Pregnancy safety assessment of 3 months of once-weekly rifapentine and isoniazid and 9 months of daily isoniazid: a post-hoc analysis of the PREVENT TB and the iAdhere trials [abstract]","volume-title":"Am J Respir Crit Care Med","author":"Moro","year":"2016"},{"key":"2026020502172327400_bib17","author":"Centers for Disease Control and Prevention"},{"key":"2026020502172327400_bib18","article-title":"Chapter 7: Embryogenesis and fetal morphological development","volume-title":"Williams obstetrics, 24th edition","author":"Cunningham","year":"2014"},{"key":"2026020502172327400_bib19","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I","article-title":"Interval estimation for the difference between independent proportions: comparison of eleven methods","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"key":"2026020502172327400_bib20","author":"Lowry"},{"key":"2026020502172327400_bib21","first-page":"1","article-title":"Estimated pregnancy rates and rates of pregnancy outcomes for the United States, 1990\u20132008","volume":"60","author":"Ventura","year":"2012","journal-title":"Natl Vital Stat Rep"},{"key":"2026020502172327400_bib22","volume-title":"Update on overall prevalence of major birth defects, Atlanta, Georgia, 1978\u20132005.","author":"U.S. Centers for Disease Control and Prevention","year":"2008"},{"key":"2026020502172327400_bib23","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.2105\/AJPH.90.9.1452","article-title":"Subfertility and risk of spontaneous abortion","volume":"90","author":"Gray","year":"2000","journal-title":"Am J Public Health"},{"key":"2026020502172327400_bib24","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0002-9378(99)70568-5","article-title":"Epidemiology of miscarriage and its relation to other reproductive events in Finland","volume":"181","author":"Hemminki","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"2026020502172327400_bib25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/bmj.299.6698.541","article-title":"Influence of past reproductive performance on risk of spontaneous abortion","volume":"299","author":"Regan","year":"1989","journal-title":"BMJ"},{"key":"2026020502172327400_bib26","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(09)61877-8","article-title":"Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines","volume":"374","author":"Black","year":"2009","journal-title":"Lancet"},{"key":"2026020502172327400_bib27","first-page":"65","article-title":"Metropolitan Atlanta Congenital Defects Program 40th Anniversary Edition Surveillance Report: reporting birth defects surveillance data 1968\u20132003","volume":"79","author":"Correa","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"2026020502172327400_bib28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/096914139700400402","article-title":"Antenatal screening for Down\u2019s syndrome","volume":"4","author":"Wald","year":"1997","journal-title":"J Med Screen"},{"key":"2026020502172327400_bib29","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1590\/1414-431X20143895","article-title":"Prenatal management, pregnancy and pediatric outcomes in fetuses with septated cystic hygroma","volume":"47","author":"Sanhal","year":"2014","journal-title":"Braz J Med Biol Res"},{"key":"2026020502172327400_bib30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000086900","article-title":"Risk factors for nondisjunction of trisomy 21","volume":"111","author":"Sherman","year":"2005","journal-title":"Cytogenet Genome Res"},{"key":"2026020502172327400_bib31","first-page":"72063","article-title":"Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling: final rule","volume":"79","author":"Food and Drug Administration, HHS","year":"2014","journal-title":"Fed Regist"},{"key":"2026020502172327400_bib32","article-title":"U.S. Department of Health and Human Services","author":"National Institute of Health","year":"2017"},{"key":"2026020502172327400_bib33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2165\/00002018-200124070-00006","article-title":"Drug treatment for tuberculosis during pregnancy: safety considerations","volume":"24","author":"Bothamley","year":"2001","journal-title":"Drug Saf"},{"key":"2026020502172327400_bib34","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/infdis\/173.2.488","article-title":"Effect of pregnancy on the risk of developing active tuberculosis","volume":"173","author":"Espinal","year":"1996","journal-title":"J Infect Dis"},{"key":"2026020502172327400_bib35","doi-asserted-by":"crossref","first-page":"e0154825","DOI":"10.1371\/journal.pone.0154825","article-title":"Latent tuberculosis in pregnancy: a systematic review","volume":"11","author":"Malham\u00e9","year":"2016","journal-title":"PLoS One"},{"key":"2026020502172327400_bib36","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/cid\/cis732","article-title":"Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps","volume":"55","author":"Mathad","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2026020502172327400_bib37","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1055\/s-0029-1214244","article-title":"Universal tuberculosis screening in pregnancy","volume":"26","author":"Schwartz","year":"2009","journal-title":"Am J Perinatol"},{"key":"2026020502172327400_bib38","doi-asserted-by":"crossref","first-page":"10S","DOI":"10.1378\/chest.86.3.10S","article-title":"Pregnancy and tuberculosis","volume":"86","author":"Snider","year":"1984","journal-title":"Chest"},{"key":"2026020502172327400_bib39","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1164\/rccm.201106-1083OC","article-title":"Risk of tuberculosis in pregnancy: a national, primary care\u2013based cohort and self-controlled case series study","volume":"185","author":"Zenner","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502172327400_bib40"},{"key":"2026020502172327400_bib41","first-page":"517","article-title":"Limb deformity in a newborn. Is rifampicin just an innocent bystander?","volume":"19","author":"Kalayci","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2026020502172327400_bib42","first-page":"65","article-title":"Treatment of tuberculosis during pregnancy","volume":"122","author":"Snider","year":"1980","journal-title":"Am Rev Respir Dis"},{"key":"2026020502172327400_bib43","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0140-6736(77)91447-7","article-title":"Rifampicin in pregnancy","volume":"2","author":"Steen","year":"1977","journal-title":"Lancet"},{"key":"2026020502172327400_bib44","author":"National Institute of Health"},{"key":"2026020502172327400_bib45","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/cid\/civ991","article-title":"Toward earlier inclusion of pregnant and postpartum women in tuberculosis drug trials: consensus statements from an international expert panel","volume":"62","author":"Gupta","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2026020502172327400_bib46","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/522182","article-title":"Immune reconstitution syndrome and exacerbation of infections after pregnancy","volume":"45","author":"Singh","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2026020502172327400_bib47","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-0897.2010.00836.x","article-title":"The immune system in pregnancy: a unique complexity","volume":"63","author":"Mor","year":"2010","journal-title":"Am J Reprod Immunol"},{"key":"2026020502172327400_bib48","author":"Centers for Disease Control and Prevention"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/15\/5\/570\/66733005\/annalsats_15_5_570.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/15\/5\/570\/66733005\/annalsats_15_5_570.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:17:32Z","timestamp":1770275852000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/15\/5\/570\/8456805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,1]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,1]]},"published-print":{"date-parts":[[2018,5,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201704-326oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,5]]},"published":{"date-parts":[[2018,5,1]]}}}